The scandal of poor epidemiological research

British Medical Journal

Volumn 329, Issue 7471, 2004, Pages 868-869

  Von Elm, Erik ^a   Egger, Matthias ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; EDITORIAL; HORMONE SUBSTITUTION; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; EPIDEMIOLOGY; NOTE; PRACTICE GUIDELINE;

CONFOUNDING FACTORS (EPIDEMIOLOGY); EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; PRACTICE GUIDELINES;

EID: 5144220037     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (12)

1. Davey Smith G, Ebrahim S. Epidemiology - is it time to call it a day? Int J Epidemiol 2001;30:1-11.
2. Taubes G. Epidemiology faces its limits. Science 1995;269:164-9.
3. Bartlett C, Sterne J, Egger M. What is newsworthy? Longitudinal study of the reporting of medical research in two British newspapers. BMJ 2002;325:81-4.
4. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 2004;364:1219-28.
5. Lawlor DA, Davey SG, Kundu D, Bruckdorfer KR, Ebrahim S. Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet 2004;363:1724-7.
6. Pocock SJ, Collier TJ, Dandreo KJ, de Stavola BL, Goldman MB, Kalish LA, Kasten LE, McCormack VA. Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ 2004;329:883-7.
7. Humphrey LL, Chan BK, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med 2002;137:273-84.
8. Petitti D. Commentary: hormone replacement therapy and coronary heart disease: four lessons. Int J Epidemiol 2004;33:461-3.
9. Ottenbacher KJ. Quantitative evaluation of multiplicity in epidemiology and public health research. Am J Epidemiol 1998;147:615-9.
10. Altman DG. The scandal of poor medical research. BMJ 1994;308:283-4.
11. Jüni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ 2001;323:42-6.
12. Moher D, Schulz KF, Altman DG, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. JAMA 2001;285:1987-91.